Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 11, 2023
Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)
Sylvia Klineova, Rebecca Straus Farber, Tracy DeAngelis, et al.
Neuroimage. Clinical
|
August 11, 2017
The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS
Matteo Pardini, Maria Petracca, Asaff Harel, et al.
Discovery Medicine
|
October 1, 2020
Defining the role of T lymphocytes in the immunopathogenesis of neuromyelitis optica spectrum disorder
Dennis Fitzgerald, Micheline Laurent, Michael Funaro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 18, 2018
Brain microstructural injury occurs in patients with RRMS despite 'no evidence of disease activity'
Asaff Harel, Dylan Sperling, Maria Petracca, et al.
Frontiers in Neurology
|
March 14, 2022
A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines
Ahmad A Ballout, Anna Babaie, Michael Kolesnik, et al.
Molecular Therapy. Methods & Clinical Development
|
July 7, 2016
An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain
Bonnie Reinhart, William F Goins, Asaff Harel, et al.
JAMA Neurology
|
March 16, 2021
Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
Arpan Patel, James Sul, Marc L Gordon, et al.
Multiple Sclerosis and Related Disorders
|
August 15, 2021
Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)
Sylvia Klineova, Asaff Harel, Rebecca Straus Farber, et al.
Cureus
|
July 8, 2021
Large Adult Spinal Diffuse Midline Histone H3 Lysine27-to-Methionine-Mutant Glioma With Intramedullary and Extramedullary Components Presenting With Progressive Hydrocephalus: A Case Report Highlighting Unique Imaging Findings and Treatment
Evan H Einstein, David Bonda, Hossein Hosseini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 28, 2017
Cerebellar lobule atrophy and disability in progressive MS
Sirio Cocozza, Maria Petracca, Enricomaria Mormina, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 11, 2023
Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)
Sylvia Klineova, Rebecca Straus Farber, Tracy DeAngelis, et al.
Neuroimage. Clinical
|
August 11, 2017
The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS
Matteo Pardini, Maria Petracca, Asaff Harel, et al.
Discovery Medicine
|
October 1, 2020
Defining the role of T lymphocytes in the immunopathogenesis of neuromyelitis optica spectrum disorder
Dennis Fitzgerald, Micheline Laurent, Michael Funaro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 18, 2018
Brain microstructural injury occurs in patients with RRMS despite 'no evidence of disease activity'
Asaff Harel, Dylan Sperling, Maria Petracca, et al.
Frontiers in Neurology
|
March 14, 2022
A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines
Ahmad A Ballout, Anna Babaie, Michael Kolesnik, et al.
Molecular Therapy. Methods & Clinical Development
|
July 7, 2016
An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain
Bonnie Reinhart, William F Goins, Asaff Harel, et al.
JAMA Neurology
|
March 16, 2021
Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
Arpan Patel, James Sul, Marc L Gordon, et al.
Multiple Sclerosis and Related Disorders
|
August 15, 2021
Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)
Sylvia Klineova, Asaff Harel, Rebecca Straus Farber, et al.
Cureus
|
July 8, 2021
Large Adult Spinal Diffuse Midline Histone H3 Lysine27-to-Methionine-Mutant Glioma With Intramedullary and Extramedullary Components Presenting With Progressive Hydrocephalus: A Case Report Highlighting Unique Imaging Findings and Treatment
Evan H Einstein, David Bonda, Hossein Hosseini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 28, 2017
Cerebellar lobule atrophy and disability in progressive MS
Sirio Cocozza, Maria Petracca, Enricomaria Mormina, et al.
Page
of 4